Nov 16 (Reuters) - CSL Ltd CSL.AX :
* SEQIRUS ANNOUNCES U.S. $140 MILLION MANUFACTURING EXPANSION TO MEET GROWING DEMAND FOR INNOVATIVE CELL-BASED INFLUENZA VACCINES
Nov 16 (Reuters) - CSL Ltd CSL.AX :
* SEQIRUS ANNOUNCES U.S. $140 MILLION MANUFACTURING EXPANSION TO MEET GROWING DEMAND FOR INNOVATIVE CELL-BASED INFLUENZA VACCINES